Experian, a leading global data and technology company, today announced that Experian Assistant, an agentic AI-powered solution that greatly accelerates the data-modeling lifecycle, has won the 2025 FinTech Breakthrough Award for Analytics Innovation. For the second consecutive year, Experian received this prestigious award that recognizes those “who are dedicated to reshaping the FinTech industry and improving people’s lives through innovative technologies.” Experian Assistant enables financi...

Quectel Wireless Solutions, a global IoT solutions provider, is proud to introduce the SG882G, its latest flagship Android/Linux smart module, designed to deliver exceptional computing power, multimedia capabilities, and seamless connectivity for industrial and consumer applications. Measuring just 33.0 × 39.0 × 3.85 mm, the SG882G combines a compact form factor with powerful performance, seamlessly executing edge computing algorithms. Its high processing capability makes it ideal for space-con...

Quectel Wireless Solutions, a global IoT solutions provider, today announces the launch of the LG580P, a multi-constellation, multi-band GNSS module designed for high-precision positioning. The module supports multi-band signals across L1, L2, L5, and L6, enabling real-time kinematic (RTK) positioning and integrating a dual antenna heading algorithm for enhanced accuracy and reliability. As designers and developers seek to build devices that combine high precision positioning with low power con...

GigaDevice, a leading semiconductor company specializing in flash memory, 32-bit microcontrollers (MCUs), sensors, analog products and solutions, has announced it will attend Embedded World and showcase its latest advances in flash and MCU technologies. At the show, the company will demonstrate both the resilience and the adaptability of its solutions across four strategically important yet diverse applications: edge AI, industrial and green energy, automotive, and connectivity. Taking place ...

REVEAL GENOMICS®, a pioneering Barcelona-based biotech company dedicated to advancing precision oncology, is proud to announce the publication of a groundbreaking study demonstrating the clinical impact of HER2DX®, its genomic diagnostic test designed for early-stage HER2-positive (HER2+) breast cancer. The study, now published in ESMO Real World Data and Digital Oncology, is the first prospective real-world investigation assessing the impact of HER2DX® results on treatment decision-making in ...